The Food and Drug Administration has granted accelerated approval for bedaquiline, the first tuberculosis drug to be developed in 40 years. Bedaquiline is "a potential game changer" in treating drug-resistant tuberculosis, according to Dr. Manica Balasegaram, executive director of MSF's Access Campaign.
Civilians are fleeing their homes in Central African Republic as rebels advance toward the capital. MSF's Sylvain Groulx reports that the conflict is exacerbating health and humanitarian conditions that were already alarming.
Fighting has trapped tens of thousands of Syrians in the city of Deir al-Zor and there is urgent need for medical teams to be authorized to evacuate wounded people, according to an MSF team that visited the area in late November.
Human rights activists are pressuring the government of Nigeria to fulfill its promise to remediate lead contamination from gold mines in Zamfara District. MSF's Ivan Gayton warns that the delay is preventing treatment to hundreds of children.
MSF's Grace Tang reports that the number of people in camps for the displaced has roughly doubled since the latest fighting broke out in North Kivu, Democratic Republic of Congo. MSF is treating patients for war injuries.